Novartis’ head of drug development Vas Narasimhan talks about the company’s stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions about ...
The loss of market exclusivity for a trio of big-selling drugs in the last quarter of 2025 dragged down Novartis sales, but chief executive Vas Narasimhan says the company is equipped to ride out "the ...
Vas Infrastructure Limited (CN) is an India-based company, which is engaged in the business of development of real estate, residential facilities including construction and infrastructure. The Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results